Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h

Google maps

Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :

Inflammatory markers associated with development of diabetes in people taking HIV therapy

Low-level elevations in important markers of systemic inflammation are associated with the development of type-2 diabetes in people taking antiretroviral therapy (ART), investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes . The authors examined the relationship between baseline levels of high sensitivity C-reactive protein (hsCRP) and...


Source Source: Aidsmap

Lithuania hosts a briefing on MDR-TB in Europe for EU member states

On 10 October, prominent speakers were invited to the Lithuanian Permanent Representation to the EU to brief Health Attachés of the different member states’ representations in Brussels on the issue of Tuberculosis and Multidrug-Resistant Tuberculosis in Europe. WHO Europe, the ECDC, the STOP TB Partnership, the TB Europe Coalition, the European Commission and 10 member...


Leaked TPP draft reveals extreme rights holder position of US, Japan, outraged observers say

Critics poring over a newly leaked alleged draft of the Trans-Pacific Partnership agreement (TPP) intellectual property chapter say it shows the United States is taking an all-out lurch toward greater protection and less access, causing outrage among public interest groups. On 16 October, Wikileaks leaked a draft of the TPP agreement from the Ho Chi Minh City, Vietnam, round last May....


Female drug users in Georgia face barriers to access therapy

Many women addicted to drugs in Georgia are unable to access harm-reduction programmes because of stigma and discrimination, including from health professionals. Ed Holt reports.   Women who use drugs in Georgia are failing to access potentially life-saving services as deep-rooted conservative attitudes towards women's roles in society stop them seeking, and receiving,...


Source Source: The Lancet

IDWeek 2014: NNRTIs and protease inhibitors both good for first ART, channeling affects choices

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) and boosted protease inhibitors work equally well for people starting HIV treatment for the first time, with similar viral suppression, CD4 cell gains, and disease progression, according to a large meta-analysis presented at IDWeek 2014 last week in Philadelphia. A related study shed light on factors...